J. Vannice

发表

Interleukin-1 receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized mice.

R. Kitazawa, R. Kimble, R. Pacifici, 1994, The Journal of clinical investigation.

Circulating IL-1ra and IL-10 levels are increased but do not predict the development of acute respiratory distress syndrome in at-risk patients.

P. Parsons, F. Moore, M. Moss, 1997, American journal of respiratory and critical care medicine.

A second tumor necrosis factor receptor gene product can shed a naturally occurring tumor necrosis factor inhibitor.

M. T. Brewer, T. Kohno, R. Thompson, 1990, Proceedings of the National Academy of Sciences of the United States of America.

Interleukin-1 receptor antagonist decreases bone loss and bone resorption in ovariectomized rats.

R. Thompson, R. Kimble, R. Pacifici, 1994, The Journal of clinical investigation.

Interleukin-1 receptor antagonist prevents sepsis-induced inhibition of protein synthesis.

T. Vary, R. Cooney, J. Vannice, 1994, The American journal of physiology.

The human transforming growth factor alpha promoter directs transcription initiation from a single site in the absence of a TATA sequence

R. Derynck, A. Levinson, J. Vannice, 1988, Molecular and cellular biology.

Interleukin-1 receptor antagonist halts the progression of established crescentic glomerulonephritis in the rat.

R. Atkins, H. Lan, D. Nikolic-Paterson, 1995, Kidney international.

Suppression of experimental crescentic glomerulonephritis by the interleukin-1 receptor antagonist.

R. Atkins, H. Lan, D. Nikolic-Paterson, 1993, Kidney international.

Properties of the human hepatitis B virus enhancer: position effects and cell-type nonspecificity

A. Levinson, J. Vannice, 1988, Journal of virology.

Induction of the acute-phase reactant, alpha 1-acid glycoprotein, by glucocorticoids in rat hepatoma cells.

J. Taylor, G. Ringold, J. Vannice, 1983, DNA.

Interleukin-1 receptor antagonist ameliorates experimental anti-glomerular basement membrane antibody-associated glomerulonephritis.

L. Feng, C. Wilson, J. Vannice, 1994, The Journal of clinical investigation.

Suppression of experimental glomerulonephritis by the interleukin-1 receptor antagonist: inhibition of intercellular adhesion molecule-1 expression.

R. Atkins, H. Lan, D. Nikolic-Paterson, 1994, Journal of the American Society of Nephrology : JASN.

Post-insult treatment with interleukin-1 receptor antagonist decreases oxidative lung injury in rats given intratracheal interleukin-1.

S. Rohrbach, J. Repine, J. Leff, 1994, American journal of respiratory and critical care medicine.

Persistent bone-sparing effect of interleukin-1 receptor antagonist: A hypothesis on the role of IL-1 in ovariectomy-induced bone loss

R. Kitazawa, R. Kimble, R. Pacifici, 1994, Calcified Tissue International.

Glucocorticoid-mediated induction of alpha 1-acid glycoprotein: evidence for hormone-regulated RNA processing.

J. Taylor, G. Ringold, J. Vannice, 1984, Proceedings of the National Academy of Sciences of the United States of America.

Inhibition of protein synthesis stimulates the transcription of human beta-interferon genes in Chinese hamster ovary cells.

F. McCormick, G. Ringold, J. Vannice, 1984, Proceedings of the National Academy of Sciences of the United States of America.

TheHumanTransforming GrowthFactor AlphaPromoter Directs Transcription Initiation froma Single SiteintheAbsence ofa TATA Sequence

A. Levinson, J. Vannice, E. Jakobovits, 1988 .

Monocytic secretion of interleukin-1 receptor antagonist in normal and osteoporotic women: effects of menopause and estrogen/progesterone therapy.

R. Kimble, R. Pacifici, J. Vannice, 1993, The Journal of clinical endocrinology and metabolism.

Glucocorticoid Receptors and the Control of Gene Expression

J. Northrop, G. Ringold, M. Danielsen, 1987 .

Different receptor mechanisms mediate the pyrogenic and behavioral effects of interleukin 1.

R. Dantzer, N. Rothwell, R. Bluthé, 1992, Proceedings of the National Academy of Sciences of the United States of America.

Interleukin-1 receptor antagonist improves survival and preserves organ adenosine-5'-triphosphate after hemorrhagic shock.

E. DeMaria, H. Reines, J. Pellicane, 1993, Surgery.

Differential expression of proinflammatory cytokines and their inhibitors during the course of meningococcal infections.

R. Sauerwein, J. V. D. van der Meer, M. Deuren, 1994, The Journal of infectious diseases.

Glucocorticoid regulation of gene expression: mouse mammary tumor virus as a model system.

F. Lee, D. Dobson, G. Ringold, 1983, Recent progress in hormone research.

Simultaneous block of interleukin-1 and tumor necrosis factor is required to completely prevent bone loss in the early postovariectomy period.

R. Kimble, R. Pacifici, J. Vannice, 1995, Endocrinology.

Interleukin-1 or tumor necrosis factor-alpha antagonists do not inhibit graft-versus-host disease induced across the major histocompatibility barrier in mice.

B. Blazar, P. Taylor, D. Vallera, 1995, Transplantation.

Structure of the rat alpha 1-acid glycoprotein gene

J. Taylor, G. Clawson, E. Smuckler, 1985, Molecular and cellular biology.

Structure of the Rat xl-Acid Glycoprotein Gene

G. Clawson, E. Smuckler, J. Vannice, 2022 .

Glucocorticoid-mediated induction of a ,-acid glycoprotein : Evidence for hormone-regulated RNA processing ( in vitro transcription / gene expression / glucocorticoid action )

G. Ringold, J. Vannice, John M. TAYLORt, 2022 .

The inhibitor cytokine interleukin-1 receptor antagonist synergistically augments cyclosporine immunosuppression in a rat cardiac allograft model.

M. Csete, R. Busuttil, A. Shaked, 1995, The Journal of surgical research.

Interleukin-1 receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized mice.

R. Kitazawa, R. Kimble, R. Pacifici, 1994, The Journal of clinical investigation.